Have a personal or library account? Click to login
Myoclonic Jerks, Exposure to Many Cats, and Neurotoxoplasmosis in an Immunocompetent Male Cover

Myoclonic Jerks, Exposure to Many Cats, and Neurotoxoplasmosis in an Immunocompetent Male

Open Access
|Jan 2018

Figures & Tables

Video 1

Demonstration of Myoclonic Jerks in our Patient. This video shows multifocal, myoclonic jerks of the patient’s head, right upper limb, fingers, and legs. These involuntary intermittent jerky movements took place during the day or night but only during sleep without causing incontinence or arousal. We found an observable pattern of three to five sequences of muscle contractions per minute, each lasting 2–3 minutes followed by a period of non- observable phenomena of 20–30 minutes’ duration. These movements occurred four to six times daily for 7 days. Myoclonus was not observed after spontaneous arousal or while the patient was awake. The patient was always unaware of those events that subsided spontaneously without benzodiazepines.

Table 1

Medical Investigations

Tests Performed on AdmissionResultReference Range
Blood test
WBCs13.8 × 109/L4.5–11.0 × 109/L
Eosinophils14.1%0.0–0.6%
Hemoglobin15.2 g/dL14.0–17.5 g/dL
Mean corpuscular volume83.2 fL/red cell80–96 fL/red cell
Platelet count350 × 103/µL156–373 × 103/µL
Serum potassium4.1 mmol/L3.5–5.1 mmol/L
Serum sodium138 mmol/L135–145 mmol/L
Serum creatinine0.8 mg/dL0.5–1.2 mg/dL
BUN11 mg/dL3–20 mg/dL
Uric acid4.5 mg/dL2.5–8 mg/dL
Alanine aminotransferase60 IU/L20–60 IU/L
Aspartase aminotransferase40 IU/L5–40 IU/L
Gamma glutamyl transpeptidase60 U/L8–61 IU/L
Lactate dehydrogenase330 IU/L105–333 IU/L
Alkaline phosphatase129 U/L40–129 IU/L
Albumin4.9 g/dL3.5–5.5 g/dL
Albumin-corrected calcium9.6 mg/dL9.6–11.2 mg/dL
CRP31.1 mg/dL0.0–1.0 mg/dL
Fasting blood sugar80 mg/dL60–120 mg/dL
VDRL testNon-reactiveNon-reactive or reactive
FTA-ABSNegativePositive or negative
Elisa for HIVNon-reactiveNon-reactive or reactive
Antistreptolysin O titer90 IU/mL0–200 IU/mL
Toxoplasma gondii IgG antibodies198 IU/mLPositive: greater than 1.09 IU/mL
Toxoplasma gondii IgM antibodiesPositivePositive or negative
Toxoplasma gondii specific IgG avidityHigh avidity (AI > 50%)Low avidity (AI ≤ 50%)High avidity (AI > 50%)
Herpes virus 1 IgG antibodiesLess than 0.9Index negative: Less than 0.9
Herpes virus 1 IgM antibodiesLess than 0.9Index negative: less than 0.9
Herpes virus 2 IgG antibodiesLess than 0.9Index negative: Less than 0.9
Herpes virus 2 IgM antibodiesLess than 0.9Index negative: less than 0.9
CMV IgG antibodies0.800 UA/mLNegative: less than 1.5 UA/mL
CMV IgM antibodies0.778 UA/mLNegative: less than 1.1 UA/mL
EBV IgG antibodies3.3Positive: Greater than 22
EBV IgM antibodies0.1Negative: less than 0.8
Hepatitis BsAGNegativePositive or negative
Hepatitis C IgG antibodiesNegativePositive or negative
Hepatitis C IgM antibodiesNegativePositive or negative
Echinococcus granulosus IgG antibodyNegativePositive or negative
Anti-double stranded DNANegativePositive or negative
Antinuclear antibodyNegativePositive or negative
Perinuclear antineutrophil cytoplasmic antibodies5.42 U/mLNegative: less than 10.0 U/mL
Cytoplasmic antineutrophil cytoplasmic antibodies3.73 U/mLNegative: Less than 10.0 U/mL
PCR for viral infections or toxoplasmosisTests not obtainedNegative or positive
Other investigations
Mantoux testNegativePositive or negative
ElectrocardiogramSinus tachycardiaNormal or abnormal
Chest X-rayNormalNormal or abnormal
EchocardiogramNormal ejection fraction 75%Normal or abnormal
CT scan of the brain with contrastNormalNormal or abnormal
MRI/MRA scans of the brainNormalNormal or abnormal
CSF analysisCSF opening pressure was 14 cm of H2O. CSF contained 47 cells/mm3, 0.8 g/L of proteins, and the glucose concentration was 60 mg/dL. CSF culture showed no bacterial growth and cytology was negative for neoplastic cells. VDRL was non-reactive and India ink test for Cryptococcus neoformans was negative
Toxoplasma gondii IgG antibodies in CSF20 IU/mLPositive: greater than 1.09 IU/mL
Toxoplasma gondii IgM antibodies in CSFPositivePositive or negative
Tests performed in the follow-up blood test
Toxoplasma gondii IgG antibodies20 IU/mLPositive: greater than 1.09 IU/mL
Toxoplasma gondii IgM antibodiesPositivePositive or negative
PCR for viral infections or toxoplasmosisTests not obtainedNegative or positive
Other investigations
Scalp EEGNormalNormal or abnormal
EMG and nerve conduction studiesNormalNormal or abnormal
PCR for viral infections or toxoplasmosis in CSFTests not obtainedNegative or positive
Video-EEG, polysomnography and jerk locked backed averaging studiesTests not obtainedNormal or abnormal

[i] Abbreviations: BUN, Blood Urea Nitrogen; BsAG, B surface antigen; CMV, Cytomegalovirus; CRP, C-reactive Protein; CSF, Cerebrospinal Fluid; CT, Computed Tomography; DNA, Deoxyribonucleic Acid; EBV, Epstein–Barr Virus; EEG, Electroencephalogram; ELISA, Enzyme-linked Immunosorbent Assay; EMG, Electromyography; FTA-ABS, Fluorescent Treponema Pallidum Antibody Absorption; HIV, Human Immunodeficiency Virus; Ig, Immunoglobulin; MRI/MRA, Magnetic Resonance Imaging/Magnetic Resonance Angiography; PCR, Polymerase Chain Reaction; VDRL, Venereal Disease Research Laboratory; WBC, White Blood Cell.

Table 2

Medical Treatment

DosagePeriod of Treatment
Intravenous therapy initiated on admission day
Trimethoprim–sulfamethoxazole160 mg/800 mg 3 times daily2 weeks
Normal saline isotonic solution1 L daily1 week
Pantoprazole40 mg twice daily3 days
Oral drugs initiated on admission day
Carbamazepine200 mg 2 times daily6 days
Paracetamol1 g three times daily7 days
Other oral drugs
Trimethoprim–sulfamethoxazole80 mg/400 mg per tablet 2 tablets 2 times daily4 weeks initiated on day 15
Pantoprazole40 mg once daily14 days initiated on day 4
Table 3

Differential Diagnosis of the Causes of Myoclonus

CausesDisease states
EndocrineHyperosmolar hyperglycemic state
Ischemic statesBrain hypoxia, strokes
VasculitisCNS vasculitis
AutoimmuneSystemic lupus erythematosus
DrugsTramadol, morphine, hydromorphine, pethidine, quinolones, benzodiazepine, gabapentin, sertraline, lamotrigine, and any drug or chemical poisoning
Infection–sepsisNeurosyphilis, HIV encephalopathy, CNS toxoplasmosis in HIV-AIDS, Lyme disease
NeurodegenerativeParkinson’s disease, multiple sclerosis, Alzheimer’s disease
TraumaHead or spinal cord injury
NeoplasiaBrain tumors
GeneticMitochondrial encephalomyopathy, lipid storage disease
Organ failureKidney or liver failure
Other causesNegative myoclonus, tremor, opsoclonus myoclonus syndrome, Creutzfeldt–Jacob disease, Tourette syndrome

[i] Abbreviations: AIDS, Acquired Immune Deficiency Syndrome; CNS, Central Nervous System; HIV, Human Immunodeficiency Virus.

DOI: https://doi.org/10.5334/tohm.408 | Journal eISSN: 2160-8288
Language: English
Submitted on: Sep 24, 2017
Accepted on: Dec 14, 2017
Published on: Jan 5, 2018
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2018 Antonio Jose Reyes, Kanterpersad Ramcharan, Stanley Lawrence Giddings, Samuel Aboh, Fidel Rampersad, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.